Mark Cuban Cost Plus Drug Company and 9amHealth Join Forces
In a groundbreaking move aimed at addressing obesity concerns, the Mark Cuban Cost Plus Drug Company, PBC, has announced a strategic partnership with 9amHealth, a pioneer in comprehensive cardiometabolic care. With obesity increasingly recognized as a major public health issue, this collaboration is set to provide affordable treatment options and supportive care for employers across the nation.
A New Approach to Obesity Treatment
The partnership will allow employers to offer low-cost obesity medications as part of their health benefits package. By leveraging Cost Plus Drugs' transparent pricing model, 9amHealth can provide effective medications while maintaining a clinically validated approach to obesity management. The collaboration will streamline access for employees, ensuring that they can receive necessary treatments without facing excessive costs.
Currently, 9amHealth is working to integrate Cost Plus Drugs' low-cost oral medications into its offerings, making it easier for employers to implement effective obesity management programs. These new offerings also include access to branded GLP-1 obesity medications via clear, upfront pricing through direct partnerships with manufacturers. This enables self-insured employers to provide their employees with affordable healthcare solutions for managing weight and related chronic conditions like diabetes, hypertension, and high cholesterol.
Responding to Rising Demand
The demand for weight-loss medications has surged, particularly as more organizations recognize the importance of supporting employee health. According to recent studies, obesity coverage is a central issue for many employers, who are eager to support their employees with clinically efficient and cost-effective solutions. By collaborating, Mark Cuban's Cost Plus Drugs and 9amHealth are responding to this urgent need by presenting an accessible and pragmatic solution that aims to improve overall workforce health.
Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, expressed enthusiasm about the partnership, stating, “We are thrilled to collaborate with 9amHealth in our mission to make prescription drugs more affordable for consumers.” This commitment to transparent pricing underlines their shared goal of expanding access to vital healthcare services.
Comprehensive Care Beyond Medications
In addition to providing affordable medications, the partnership emphasizes a holistic approach to obesity management. Employees will benefit from virtual medical care, which connects them with a dedicated team of obesity medicine specialists at 9amHealth. This includes not only physicians but also endocrinologists and clinical pharmacists, allowing for a well-rounded care experience from the comfort of their homes.
Moreover, 9amHealth highlights the importance of linking patients to nutritional support through registered dietitians and ongoing care management. With services like at-home lab testing and prescription delivery, employees can receive continuous support tailored to their specific health needs.
Paul Geevarghese, COO and Co-Founder of 9amHealth, emphasized the groundbreaking potential of this collaboration, noting, “We’re not only lowering the cost of medications, we’re also connecting members to real, human care specialists in obesity and diabetes.” This integrated approach ensures that employees not only receive medications but also engaging and personalized healthcare management.
Key Advantages for Employers
The collaboration presents a series of key benefits for employers aiming to enhance their healthcare offerings:
- - Expert Virtual Medical Care: Access to a specialized 9amHealth Care Team, including obesity medicine physicians and endocrinologists.
- - Transparent Pricing: Low-cost first-generation obesity medications through Cost Plus Drugs, providing predictable pricing for employers.
- - Comprehensive Coverage: Options for branded GLP-1 medications at set monthly costs.
- - Convenient Services: At-home lab testing, prescription delivery, and 24/7 clinical support streamline the healthcare experience.
- - Scalable Solutions: Effective management of obesity and related chronic conditions across diverse employee populations, making health benefits more robust.
Finally, as the need for accessible and evidence-based obesity management continues to rise, the collaboration between Mark Cuban Cost Plus Drug Company and 9amHealth represents a strong commitment towards enhancing employee health and reducing the costs associated with obesity treatment. Employers are encouraged to explore these innovative solutions to enrich their health benefits offerings.
For more information about how to bring this solution to your workforce, visit
www.join9am.com/employers.